Hypoalbuminaemia does not impair Diprifusor performance during sedation with propofol

British Journal of Anaesthesia

Volumn 94, Issue 4, 2005, Pages 453-458

  Cavaliere, F ^a   Conti, G ^a   Moscato, U ^a   Meo, F ^a   Pennisi, M A ^a   Costa, R ^a   Proietti, R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Anaesthetics i.v., propofol; Complications, hypoalbunaemia; Infusion, target controlled; Sedation

Indexed keywords

ETILEFRINE; MORPHINE; PROPOFOL;

ACCURACY; ADULT; AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG INFUSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOALBUMINEMIA; HYPOTENSION; MALE; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SEDATION;

EID: 17044390428     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aei074     Document Type: Article

References (29)

1. Glen JB. The development of 'Diprifusor': a TCI system for propofol. Anaesthesia 1998; 53: 13-21
2. Gray JM, Kenny GNC. Development of the technology for 'Diprifusor' TCI system. Anaesthesia 1998; 53: 22-7
3. McMurray TJ, Johnston JR, Milligan KR, et al. Propofol sedation using Diprifusor target-controlled infusion in adult intensive care unit patients. Anaesthesia 2004; 59: 636-41
4. Van den Nieuwenhuyzen MCO, Engbers FHM, Vuyk EJ, Burm AGL. Target-controlled infusion systems. Role in anaesthesia and analgesia. Clin Pharmacokinet 2000; 38: 181-90
5. Swinhoe CF, Peacock JE, Glen JB, Reilly CS. Evaluation of the predictive performance of a 'Diprifusor' TCI system. Anaesthesia 1998; 53: 61-7
6. Servin FS. TCI compared with manually controlled infusion of propofol: a multicentre study. Anaesthesia 1998; 53: 82-6
7. Pichette V, Geadah D, du Souich P. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit. Drug Metab Dispos 1999; 27: 81-5
8. Romano S, Fdez de Gatta MM, Calvo MV, Caballero D, Dominguez-Gil A, Lanao JM. Population pharmacokinetics of amikacin in patients with haematological malignancies. J Antimicrob Chemother 1999; 44: 235-42
9. Mimoz O, Soreda S, Padoin C, Tod M, Petitjean O, Benhamou D. Ceftriaxone pharmacokinetics during iatrogenic hydroxyethyl starch-induced hypoalbuminemia: a model to explore the effects of decreased protein binding capacity on highly bound drugs. Anesthesiology 2000; 93: 735-43
10. Lagneau F, Perbet S, Delefosse D, Wernet A, Stocco J, Marty J. Drugs pharmacokinetics in ICU patients: consequences of hypoalbuminemia upon drugs monitoring and dosing scheme. Intensive Care Med 2004; 30: 1247
11. Costela JL, Jiménez R, Calvo R, Suárez E, Carlos R. Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis. Acta Anaesthesiol Scand 1996; 40: 741-5
12. Zamacona MK, Suárez E, Aguilera L, Rodriguez-Saslain JM, Aguirre C, Calvo R. Serum protein binding of propofol in critically ill patients. Acta Anaesthesiol Scand 1997; 41: 1267-72
13. Plummer GF. Improved method for the determination of propofol in blood by high performance liquid chromatography with fluorescence detection. J Chromatogr 1978; 421: 171-6
14. Varvel JR, Donoho DL, Shafer SL. Measuring the performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 1992; 20: 63-94
15. University of Düsseldorf. www.psycho.uni-duesseldorf.de/aap/projects/gpower/. Accessed September 20, 2004
16. Cohen J. Statistical Power Analysis for the Behavioural Sciences, 2nd edn. New York: Academic Press, 1977
17. Schüttler J, Kloos S, Schwilden H, Stoeckel H. Total intravenous anaesthesia with propofol and alfentanil by computer assisted infusion. Anaesthesia 1988; 43: 2-7
18. Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gutteridge JM, Evans TW. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004; 32: 755-9
19. Alderson P, Bunn F, Lefebvre C, Li WP, Li L, Roberts I, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2002; 1: CD001208
20. Polimood TB, Park GR. Debate: albumin administration should be avoided in the critically ill. Crit Care 2000; 4: 151-5
21. Consensus conference. Use of albumin solutions in surgical anesthesia and surgical intensive care of adults. Ann Fr Anesth Reanim 1996; 15: 407-568
22. Haynes GR, Navickis RJ, Wilkes MM. Albumin administration. What is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol 2003; 20: 771-93
23. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE study investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350 2247-56
24. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-9
25. Wood M. Plasma binding and limitation of drug access to site of action. Anesthesiology 1991; 75: 721-3
26. Grandison MK, Boudinot FD. Age-related changes in protein binding of drugs. Implication for therapy. Clin Pharmacokinet 2000; 38: 271-90
27. Bertucci C, Domenici E. Reversibile and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem 2002; 9: 1463-81
28. Mazoit JX, Samii K. Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol 1999; 47: 35-42
29. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-63